| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone |
| Available forms, composition and doses of Synphasic: |
| Tablets; Oral-21; Ethinyl Estradiol 0.035 mg; Ethinyl Estradiol 0.035 mg; Norethindrone 1 mg; Norethindrone 0.5 mgTablets; Oral-28; Ethinyl Estradiol 0.035 mg; Ethinyl Estradiol 0.035 mg; Norethindrone 1 mg; Norethindrone 0.5 mg |
| Synphasic medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerSyntex |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Select 1 / 35 28-Day | Ethinyl Estradiol; Norethindrone | Pfizer |
| Sinovula | Ethinyl Estradiol; Norethindrone | Chiesi |
| Synfase | Ethinyl Estradiol; Norethindrone | Pfizer |
| Synphase | Ethinyl Estradiol; Norethindrone | Pfizer |
| Synphasec | Ethinyl Estradiol; Norethindrone | Grunenthal |
| Synphasic 21 | Ethinyl Estradiol; Norethindrone | Pfizer; Syntex |
| Synphasic 28 | Ethinyl Estradiol; Norethindrone | Pfizer; Syntex |
| Triella | Ethinyl Estradiol; Norethindrone | Janssen; Codepharma Laboratoire |
| Tri-Norinyl | Ethinyl Estradiol; Norethindrone | Pfizer; Watson Pharmaceuticals |
| TriNovum | Ethinyl Estradiol; Norethindrone | Janssen; Edward Keller |